Evidence map›Paper›PMID 36137862›Full record

ReviewHearing research2022

An overview of the HASPI and HASQI metrics for predicting speech intelligibility and speech quality for normal hearing, hearing loss, and hearing aids.

James M Kates, Kathryn H Arehart

Abstract readReview
In one paragraph

Review in Hearing research, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed.

  1. Review
  2. Article
  3. Review
  4. Article
  5. Article
  6. Article
  7. Article
  8. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors.

James M KatesDepartment of Speech Language and Hearing Sciences, University of Colorado, Boulder, CO 80309, USA. Electronic address: James.Kates@colorado.edu.
Kathryn H ArehartDepartment of Speech Language and Hearing Sciences, University of Colorado, Boulder, CO 80309, USA.

Funding

Characterizing Variability in Hearing Aid Outcomes Among Older AdultsR01DC012289 · NIDCD · NORTHWESTERN UNIVERSITY · PI SOUZA, PAMELA E. · 2012 to 2021
$3.7M
NIDCD NIH HHS R01 DC012289
6 · The paper itself

Abstract

Alterations of the speech signal, including additive noise and nonlinear distortion, can reduce speech intelligibility and quality. Hearing aids present an especially complicated situation since these devices may implement nonlinear processing designed to compensate for the hearing loss. Hearing-aid processing is often realized as time-varying multichannel gain adjustments, and may also include frequency reassignment. The challenge in designing metrics for hearing aids and hearing-impaired listeners is to accurately model the perceptual trade-offs between speech audibility and the nonlinear distortion introduced by hearing-aid processing. This paper focuses on the Hearing Aid Speech Perception Index (HASPI) and the Hearing Aid Speech Quality Index (HASQI) as representative metrics for predicting intelligibility and quality. These indices start with a model of the auditory periphery that can be adjusted to represent hearing loss. The peripheral model, the speech features computed from the model outputs, and the procedures used to fit the features to subject data are described. Examples are then presented for using the metrics to measure the effects of additive noise, evaluate noise-suppression processing, and to measure the differences among commercial hearing aids. Open questions and considerations in using these and related metrics are then discussed.

Indexed as

DeafnessHearing AidsHearing LossHearing Loss, SensorineuralSpeech PerceptionBenchmarkingHearingHumansSpeech IntelligibilityAuditory peripheral modelHearing aidsHearing lossSpeech intelligibilitySpeech quality ratings

Identifiers

PMID36137862
PMCPMC10833438

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.